The Case for Biennial Retinopathy Screening in Children and Adolescents

Author:

Maguire Ann1,Chan Albert1,Cusumano Janine1,Hing Stephen12,Craig Maria13,Silink Martin14,Howard Neville1,Donaghue Kim14

Affiliation:

1. Institute of Endocrinology and Diabetes, The Children’s Hospital at Westmead, Sydney, NSW, Australia

2. Ophthalmology Department, The Children’s Hospital at Westmead, Sydney, NSW, Australia

3. University of New South Wales, Sydney, New South Wales, Australia

4. University of Sydney, Sydney, New South Wales, Australia

Abstract

OBJECTIVE—Current guidelines recommend annual retinopathy screening 2 years after onset (for pubertal-onset type 1 diabetes) and after 5 years (or age 11, whichever is earlier) for prepubertal onset. Our aim was to describe the natural history of retinopathy and to explore optimal retinal screening intervals for children and adolescents (aged <20 years) screened according to these guidelines. RESEARCH DESIGN AND METHODS—More than 1,000 children and adolescents, followed longitudinally, were screened for retinopathy using seven-field stereoscopic fundus photography through dilated pupils. Of these, 668 had baseline and follow-up retinal screening. Using generalized estimating equations, we compared the risk of retinopathy with baselines at yearly intervals, in older and younger groups, in higher risk groups (diabetes duration >10 years or HbA1c >10% at any screening), and after stratification ≤10 and <10 years in duration. RESULTS—After 1 year, retinopathy did not increase significantly in the older group (n = 618, median HbA1c 8.7%, range 8.0–9.5), younger group (n = 50, median HbA1c 8.5%, range 8.0–9.2), or the higher-risk groups. Retinopathy increased significantly after 2 years in the older group (P = 0.003) but not until 6 years in the younger group (P = 0.01). In the group with HbA1c >10% recorded at any visit, retinopathy increased significantly after 2 years (P = 0.001) but not until 3 years in the group whose HbA1c was always ≤10% (P = 0.003). After the second eye assessment, retinopathy did not increase significantly until 3 and 6 years later in the older and younger groups, respectively (P = 0.028 and 0.014). CONCLUSIONS—These results suggest that adolescents (in reasonable metabolic control) could safely be screened every 2 years rather than the currently recommended 1-year interval. In younger children, the next screening interval could be >2 years later. Individuals with especially poor control, duration >10 years, or significant retinopathy should be screened more frequently.

Publisher

American Diabetes Association

Subject

Advanced and Specialized Nursing,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference29 articles.

1. Australasian Paediatric Endocrine Group: APEG Handbook on Childhood and Adolescent Diabetes. Sydney, Australasian Paediatric Endocrine Group, 1996

2. Queensland Health: Best practice guidelines for the management of type 1 diabetes in children and adolescents [article online], 2002. Available from www.health.qld.gov.au/publications/best_practice/16854.pdf. Accessed 7 September 2003

3. International Society for Pediatric and Adolescent Diabetes: ISPAD Consensus Guidelines for the Management of Type 1 Diabetes Mellitus in Children and Adolescents. Zeist, the Netherlands, Medforum, 2000

4. Canadian Diabetes Association: Clinical Practice Guidelines for the Management of Diabetes in Canada. CMAJ 159: 1–28, 1998

5. Koller HP, Fierson WM, Trese MT, Buckley EG, Ellis GS, Jr, Gross RD, Kivlin JD, Murphree AL, Schwartz RP, Lightner ES, LaFranchi S, Levine LS, Oberfield S, Owens RP, Reiter EO, Rosenfeld RG, Silverstein J, Arslanian S, Becker D, Drash A, Malone J, Klingensmith G, Levitsky L, Brink S: American Academy of Pediatrics: screening for retinopathy in the pediatric patient with type 1 diabetes mellitus. Pediatrics 101:313–314, 1998

Cited by 64 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3